Cortical neuronal apoptosis in CADASIL

Stroke

Volumn 37, Issue 11, 2006, Pages 2690-2695

  Viswanathan, Anand ^a,b   Gray, Francoise ^a   Bousser, Marie Germaine ^a   Baudrimont, Marielle ^a   Chabriat, Hugues ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Apoptosis; CADASIL; Cortex; Cortical atrophy; Lacunar infarction; White matter damage

Indexed keywords

ANTIBODY; CASPASE 3; DNA FRAGMENT; NOTCH RECEPTOR; NOTCH3 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CADASIL; CONTROLLED STUDY; GENE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MULTIINFARCT DEMENTIA; NERVE CELL; NOTCH3 GENE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; WHITE MATTER; ADULT; AGED; BRAIN CORTEX; COMPARATIVE STUDY; FEMALE; GENETICS; MALE; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; APOPTOSIS; CADASIL; CEREBRAL CORTEX; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEURONS; RECEPTORS, NOTCH;

EID: 33750953856     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000245091.28429.6a     Document Type: Article

References (35)

1. Friedlander RM. Apoptosis and caspases in neurodegenerative diseases. N Engl J Med. 2003;348:1365-1375.
2. Sairanen T, Karjalainen-Lindsberg ML, Paetau A, Ijas P, Lindsberg PJ. Apoptosis dominant in the periinfarct area of human ischaemic stroke-a possible target of antiapoptotic treatments. Brain. 2006;129:189-199.
3. Nicotera P, Lipton SA. Excitotoxins in neuronal apoptosis and necrosis. J Cereb Blood Flow Metab. 1999;19:583-591.
4. Schmalbruch H, Jensen HJ, Bjaerg M, Kamieniecka Z, Kurland L. A new mouse mutant with progressive motor neuronopathy. J Neuropathol Exp Neurol. 1991;50:192-204.
5. Raff MC, Whitmore AV, Finn JT. Axonal self-destruction and neurodegeneration. Science. 2002;296:868-871.
6. Joutel A, Vahedi K, Corpechot C, Troesch A, Chabriat H, Vayssiere C, Cruaud C, Maciazek J, Weissenbach J, Bousser MG, Bach JF, Tournier-Lasserve E. Strong clustering and stereotyped nature of notch3 mutations in CADASIL patients. Lancet. 1997;350:1511-1515.
7. Buffon F, Porcher R, Hernandez K, Kurtz A, Pointeau S, Vahedi K, Bousser MG, Chabriat H. Cognitive profile in CADASIL. J Neurol Neurosurg Psychiatry. 2006;77:175-180.
8. Baudrimont M, Dubas F, Joutel A, Tournier-Lasserve E, Bousser MG. Autosomal dominant leukoencephalopathy and subcortical ischemic stroke. A clinicopathological study. Stroke. 1993;24:122-125.
9. Ruchoux MM, Guerouaou D, Vandenhaute B, Pruvo JP, Vermersch P, Leys D. Systemic vascular smooth muscle cell impairment in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Acta Neuropathol (Berl). 1995;89:500-512.
10. Chabriat H, Pappata S, Ostergaard L, Clark CA, Pachot-Clouard M, Vahedi K, Jobert A, Le Bihan D, Bousser MG. Cerebral hemodynamics in CADASIL before and after acetazolamide challenge assessed with MRI bolus tracking. Stroke. 2000;31:1904-1912.
11. Mesulam M, Siddique T, Cohen B. Cholinergic denervation in a pure multi-infarct state: Observations on CADASIL. Neurology. 2003;60:1183-1185.
12. Chabriat H, Levy C, Taillia H, Iba-Zizen MT, Vahedi K, Joutel A, Tournier-Lasserve E, Bousser MG. Patterns of MRI lesions in CADASIL. Neurology. 1998;51:452-457.
13. Dichgans M, Holtmannspotter M, Herzog J, Peters N, Bergmann M, Yousry TA. Cerebral microbleeds in CADASIL: A gradient-echo magnetic resonance imaging and autopsy study. Stroke. 2002;33:67-71.
14. Peters N, Holtmannspotter M, Opherk C, Gschwendtner A, Herzog J, Samann P, Dichgans M. Brain volume changes in CADASIL: A serial MRI study in pure subcortical ischemic vascular disease. Neurology. 2006;66:1517-1522.
15. Seshadri S, Wolf PA, Beiser A, Elias MF, Au R, Kase CS, D'Agostino RB, DeCarli C. Stroke risk profile, brain volume, and cognitive function: The framingham offspring study. Neurology. 2004;63:1591-1599.
16. Sherriff FE, Bridges LR, Gentleman SM, Sivaloganathan S, Wilson S. Markers of axonal injury in post mortem human brain. Acta Neuropathol (Berl). 1994;88:433-439.
17. Joutel A, Andreux F, Gaulis S, Domenga V, Cecillon M, Battail N, Piga N, Chapon F, Godfrain C, Tournier-Lasserve E. The ectodomain of the notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. J Clin Invest. 2000;105:597-605.
18. Wyllie A, Duval E. In: McGee JO, Isaacson PG, Wright NA, eds. Oxford textbook of pathology. Oxford: Oxford University Press; 1992:171.
19. Adle-Biassette H, Levy Y, Colombel M, Poron F, Natchev S, Keohane C, Gray F. Neuronal apoptosis in hiv infection in adults. Neuropathol Appl Neurobiol. 1995;21:218-227.
20. Sakahira H, Enari M, Nagata S. Cleavage of cad inhibitor in cad activation and DNA degradation during apoptosis. Nature. 1998;391:96-99.
21. Ansari B, Coates PJ, Greenstein BD, Hall PA. In situ end-labelling detects DNA strand breaks in apoptosis and other physiological and pathological states. J Pathol. 1993;170:1-8.
22. Rockland KS, Drash GW. Collateralized divergent feedback connections that target multiple cortical areas. J Comp Neurol. 1996;373:529-548.
23. Bannister AP. Inter- and intra-laminar connections of pyramidal cells in the neocortex. Neurosci Res. 2005;53:95-103.
24. Thomson AM, Bannister AP. Interlaminar connections in the neocortex. Cereb Cortex. 2003;13:5-14.
25. Wang Z, McCormick DA. Control of firing mode of corticotectal and corticopontine layer v burst-generating neurons by norepinephrine, acetylcholine, and 1s,3r-acpd. J Neurosci. 1993;13:2199-2216.
26. Capurso SA, Calhoun ME, Sukhov RR, Mouton PR, Price DL, Koliatsos VE. Deafferentation causes apoptosis in cortical sensory neurons in the adult rat. J Neurosci. 1997;17:7372-7384.
27. Troncoso JC, Sukhov RR, Kawas CH, Koliatsos VE. In situ labeling of dying cortical neurons in normal aging and in alzheimer's disease: Correlations with senile plaques and disease progression. J Neuropathol Exp Neurol. 1996;55:1134-1142.
28. Mesulam MM, Geula C. Acetylcholinesterase-rich neurons of the human cerebral cortex: Cytoarchitectonic and ontogenetic patterns of distribution. J Comp Neurol. 1991;306:193-220.
29. Geula C, Mesulam MM. Cortical cholinergic fibers in aging and alzheimer's disease: A morphometric study. Neuroscience. 1989;33:469-481.
30. Peters N, Opherk C, Danek A, Ballard C, Herzog J, Dichgans M. The pattern of cognitive performance in CADASIL: A monogenic condition leading to subcortical ischemic vascular dementia. Am J Psychiatry. 2005;162:2078-2085.
31. Heimer L, Kalil R. Rapid transneuronal degeneration and death of cortical neurons following removal of the olfactory bulb in adult rats. J Comp Neurol. 1978;178:559-609.
32. Adle-Biassette H, Bell JE, Creange A, Sazdovitch V, Authier FJ, Gray F, Hauw JJ, Gherardi R. DNA breaks detected by in situ end-labelling in dorsal root ganglia of patients with aids. Neuropathol Appl Neurobiol. 1998;24:373-380.
33. Cottrez F, Manca F, Dalgleish AG, Arenzana-Seisdedos F, Capron A, Groux H. Priming of human cd4+ antigen-specific T cells to undergo apoptosis by hiv-infected monocytes. A two-step mechanism involving the gp120 molecule. J Clin Invest. 1997;99:257-266.
34. Mungas D, Jagust WJ, Reed BR, Kramer JH, Weiner MW, Schuff N, Norman D, Mack WJ, Willis L, Chui HC. MRI predictors of cognition in subcortical ischemic vascular disease and alzheimer's disease. Neurology. 2001;57:2229-2235.
35. Blum D, Chtarto A, Tenenbaum L, Brotchi J, Levivier M. Clinical potential of minocycline for neurodegenerative disorders. Neurobiol Dis. 2004;17:359-366.